Search filters

List of works by Tobias Nordström

A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml

scientific article published on 19 July 2013

A population-based study on the association between educational length, prostate-specific antigen testing and use of prostate biopsies

scientific article published on December 2015

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scientific article published on 11 June 2018

Association between PSA density and prostate cancer in men without significant MRI lesions

scientific article published on 28 February 2020

Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer.

scientific article published on 20 November 2015

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

Biomarker discrimination and calibration with MRI-targeted biopsies: an analysis with the Stockholm3 test

scientific article published on 09 November 2020

Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer

scientific article published on 20 August 2014

Detection of Prostate Cancer Using a Multistep Approach with Prostate-specific Antigen, the Stockholm 3 Test, and Targeted Biopsies: The STHLM3 MRI Project.

scientific article

Effects of increasing the PSA cutoff to perform additional biomarker tests before prostate biopsy

scientific article published on 3 October 2017

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

scientific article published on 11 June 2018

Future directions in prostate cancer testing: a comment upon results from the prospective population-based diagnostic STHLM3 study-Grönberg H et al. Lancet Oncology. 2015 Nov 9; doi:10.1016/S1470-2045(15)00361-7.

scientific article published on 2 August 2016

Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50-69 years with PSA ≥3 ng/ml

scientific article published on 26 December 2019

Poor Follow-up After Elevated Prostate-specific Antigen Tests: A Population-based Cohort Study

scientific article published on 9 February 2018

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study

scientific article (publication date: December 2015)

Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer

scientific article published on 19 December 2017

Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, Despite no recommendations for PSA screening: results from a population-based study, 2003-2011.

scientific article published on 12 October 2012

Rapid increase in multidrug-resistant enteric bacilli blood stream infection after prostate biopsy - A 10-year population-based cohort study.

scientific article published on 23 March 2015

Reply to Ola Bratt and Anna Öfverholm's Letter to the Editor re: Peter Ström, Tobias Nordström, Henrik Grönberg, Martin Eklund. The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential.

scientific article published on 26 March 2018

Survival in patients diagnosed with castration-resistant prostate cancer: a population-based observational study in Sweden

scientific article published on 08 April 2020

The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort

scientific article published on 31 August 2018

The risk of prostate cancer for men on aspirin, statin or antidiabetic medications

article

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

scientific article published in January 2021